Candidemia
📧 Sign up to get email alerts when something new happens for Candidemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-02-24Clinical Trial Update: Comparison of Candida Eradication and Serum Cidal Activity of Echinocandins [Phase 4]
Phase 4 trial comparing Candida eradication and serum cidal activity of echinocandins in patients with candidemia; results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2012-02-14Clinical Trial Update: Efficacy of Interferon-gamma in Combination With Anidulafungin for the Treatment of Candidemia [Phase 3]
Phase 3 clinical trial evaluating the efficacy of interferon-gamma in combination with anidulafungin for candidemia; the update notes the tr…
-
CLINICAL_TRIALS trial_result · 2011-10-03Clinical Trial Update: Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive Candidiasis [Phase 4]
Pfizer completed a Phase 4 trial evaluating the safety and efficacy of anidulafungin (Eraxis) in patients with candidemia or invasive candid…
-
CLINICAL_TRIALS trial_result · 2011-09-22Clinical Trial Update: Anidulafungin Pharmacokinetics in Intensive Care Unit Patients
The document provides an update on the pharmacokinetics of anidulafungin in intensive care unit patients with invasive candidiasis or candid…
-
CLINICAL_TRIALS research · 2011-06-27Clinical Trial Update: Risk Factor and Outcome of Candidemia
Clinical trial update examining risk factors and outcomes associated with candidemia.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-06-08FDA Approved: MYCAMINE — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for MYCAMINE (micafungin sodium) from Astellas Pharma US, Inc., updating its labeling with indicatio…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: Anidulafungin Candidemia/Invasive Candidiasis Intensive Care Study [Phase 3]
Phase 3 trial of anidulafungin for candidemia and invasive candidiasis in intensive care patients completed. Results were posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-04-26Clinical Trial Update: A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood. [Phase 3]
A Phase 3 study comparing voriconazole to amphotericin B followed by fluconazole in patients with candidemia has completed.
-
CLINICAL_TRIALS research · 2011-04-25Clinical Trial Update: The Relationship Between Morphology and Virulent Genes of Candida Albicans and Clinical Aspects, Surveillance of Fungemia
An ongoing clinical trial update examining how Candida albicans morphology and virulence genes relate to clinical outcomes in candidemia and…
-
CLINICAL_TRIALS trial_result · 2011-03-17Clinical Trial Update: Study and Analysis of Micafungin for Non-albican Candidemia: Efficacy, Risk Factor and Clinical Manifestation
A completed clinical trial evaluating micafungin for non-albicans candidemia, assessing efficacy, risk factors, and clinical manifestations.
-
CLINICAL_TRIALS trial_result · 2011-01-25Clinical Trial Update: Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To 11 Years Old Who Are At High Risk For Systemic Fungal Infection [Phase 2]
This Phase 2 study reports on the pharmacokinetics and safety of voriconazole in children aged 2 to 11 at high risk for systemic fungal infe…
-
CLINICAL_TRIALS trial_result · 2011-01-17Clinical Trial Update: This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis [Phase 4]
Phase 4 open-label, non-comparative trial assessing a short course of IV anidulafungin, with optional oral voriconazole, for candidemia and …
-
CLINICAL_TRIALS trial_result · 2010-02-17Clinical Trial Update: Anidulafungin In Treatment Of Candidemia In Asian Subjects [Phase 3]
Pfizer-sponsored Phase 3 trial evaluating anidulafungin for treating candidemia in Asian subjects has completed and posted results. The stud…
-
CLINICAL_TRIALS trial_result · 2010-02-09Clinical Trial Update: A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy Subjects [Phase 4]
A Phase 4 clinical trial update reporting results of a study comparing concentrations of anidulafungin and voriconazole in the lungs after i…
-
CLINICAL_TRIALS research · 2009-05-18Clinical Trial Update: Prevalence and Epidemiology of Nosocomial Candidaemia and Antifungal Susceptibility Patterns in an Italian Tertiary-Care Hospital
This clinical trial update examines the prevalence, epidemiology, and antifungal susceptibility patterns of nosocomial candidemia in an Ital…
-
FDA approval · 2009-05-04FDA Approved: CANCIDAS — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for Cancidas (caspofungin acetate) to expand its labeling.
-
CLINICAL_TRIALS trial_result · 2009-03-27Clinical Trial Update: CRITIC - Treatment of Candidemia and Invasive Candidiasis [Phase 4]
Phase 4 clinical trial update for the CRITIC study evaluating treatment of candidemia and invasive candidiasis; the study sponsored by Gilea…
-
CLINICAL_TRIALS trial_result · 2008-10-21Clinical Trial Update: The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With Candidemia and Invasive Candidiasis [Phase 3]
This Phase 3 trial compares Anidulafungin with a comparator in patients with candidemia or invasive candidiasis to evaluate safety and effic…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Anidulafungin Versus Fluconazole in the Treatment of Candidemia [Phase 3]
Phase 3 trial comparing anidulafungin to fluconazole for candidemia has completed.
-
CLINICAL_TRIALS trial_result · 2008-01-02Clinical Trial Update: Micafungin Versus Fluconazole in the Treatment of Invasive Candidiasis and Candidemia [Phase 3]
A Phase 3 trial comparing micafungin to fluconazole for invasive candidiasis and candidemia has completed.
-
FDA approval · 2007-08-06FDA Approved: MYCAMINE — Supplemental Application (Astellas Pharma US, Inc.)
The FDA approved a supplemental application for MYCAMINE (micafungin sodium) by Astellas Pharma US, Inc.
-
FDA approval · 2006-08-07FDA Approved: ERAXIS — Supplemental Application (Roerig)
The FDA approved a supplemental application for ERAXIS (anidulafungin) submitted by Roerig.
-
FDA approval · 2006-06-27FDA Approved: MYCAMINE — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for MYCAMINE (micafungin sodium) from Astellas Pharma US, Inc., expanding labeling through a supplem…